Skip to main content

Annandale Capital, LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1811739 DALLAS, TX

Position in URGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,671,640
+$618,876 QoQ
Shares Held
45,425
-22.4% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#62
of 189 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Annandale Capital, LLC holds $1,728,367 across 3 Biotechnology names. URGN ranks #1 (96.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 URGN
UroGen Pharma Ltd.
This page
45,425 $1,671,640

All Filings in URGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,671,640 45,425
2026-03-31 $1,052,764 58,552
2025-12-31 $1,418,127 60,552
2025-09-30 $14,075 70,552
2025-06-30 $1,035,062 75,552
2025-03-31 $835,605 75,552
2024-12-31 $804,628 75,552
2024-09-30 $959,510 75,552
2024-06-30 $1,267,762 75,552
2024-03-31 $1,223,280 81,552
2023-12-31 $1,227,465 81,831
2023-09-30 $1,146,452 81,831
2023-06-30 $872,825 84,331
2023-03-31 $779,218 84,331
2022-12-31 $748,015 84,331
2022-09-30 $701,633 84,331
2022-06-30 $690,670 84,331
2022-03-31 $734,523 84,331
2021-12-31 $820,275 86,254
2021-09-30 $1,450,792 86,254
2021-06-30 $1,317,098 86,254
2021-03-31 $1,680,227 86,254
2020-12-31 $1,554,297 86,254